Two Sigma Securities, LLC Viatris Inc Call Options Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$10.05 - $12.02 $126,630 - $151,452	-12,600 Reduced 40.91%	18,200 $193,000
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $347,116 - $416,724	30,800 New	30,800 $367,000
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $20,240 - $26,972	-2,200 Reduced 14.19%	13,300 $127,000
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $127,312 - $168,776	-14,600 Reduced 48.5%	15,500 $172,000
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $77,168 - $101,283	9,100 Added 43.33%	30,100 $256,000
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $182,085 - $224,541	-18,300 Reduced 46.56%	21,000 $220,000
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $561,990 - $736,481	39,300 New	39,300 $736,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.